Sales and regulatory status of fixed dose combination psychotropic drugs in India: a retrospective longitudinal study.

ABSTRACT:

Background

There is limited evidence to support use of fixed dose combination (FDC) drugs in the treatment of psychiatric disorders. This study aimed to examine the sales and regulatory status of psychotropic FDCs in India, in the context of two government regulatory initiatives.

Methods

Official documents were searched to establish an account of the initiatives and measures targeting psychotropic FDCs. This was integrated with private market data (2008 to 2020). Descriptive statistics were used to examine changes in FDC numbers/formulations and sales volumes in standard units (SU) over time.

Results

Psychotropic FDC sales volumes (percentage market share) increased from 0.8 billion SU (18.4%) in 2008 to 1.4 billion SU (20.1%) in 2020. The numbers (formulations) of FD

SUBMITTER: Bogowicz P 

PROVIDER: S-EPMC11573336 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature